US equities |
META $642.62 ▲+0.00% MU $877.55 ▲+0.00% TSLA $372.22 ▲+0.00% SPCX $147.49 ▲+0.00% NVDA $210.96 ▲+0.00% NU $15.16 ▲+0.00% SNDK $1,238.03 ▲+0.00% NBIS $158.74 ▲+0.00%
FinancialContent

Immunocore Holdings plc - American Depositary Shares (NQ:IMCR)

30.98 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Immunocore Holdings plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Immunocore Announces Proposed Convertible Senior Notes Offering
From Immunocore Holdings Limited
Via GlobeNewswire
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Immunocore's Pipeline Is Among The Strongest In Broader Biotech Universe: Analyst ↗
H.C. Wainwright analyst Patrick R. 
Via Benzinga
News headline image
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Shares of Applied Therapeutics, Inc. 
Via Benzinga
News headline image
5 Analysts Have This to Say About Immunocore Hldgs ↗
 
Via Benzinga
News headline image
Analyst Ratings for Immunocore Hldgs ↗
 
Via Benzinga
News headline image
Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation
From Immunocore Holdings Limited
Via GlobeNewswire
News headline image
Immunocore to present at the 42nd Annual J.P. Morgan Healthcare Conference
From Immunocore Holdings Limited
Via GlobeNewswire
AGC Biologics to Prepare Late Phase and Commercial Runs for Immunocore
--News Direct-- 
Via News Direct
News headline image
Immunocore Reports Third Quarter 2023 Financial Results and Provides Business Update
From Immunocore Holdings Limited
Via GlobeNewswire
News headline image
Analyst Expectations for Immunocore Hldgs's Future ↗
 
Via Benzinga
News headline image
Where Immunocore Hldgs Stands With Analysts ↗
 
Via Benzinga
News headline image
Immunocore Hldgs's Earnings Outlook ↗
 
Via Benzinga
News headline image
Immunocore announces upcoming poster presentations at SITC Annual Meeting 2023 and SMR Congress 2023
From Immunocore Holdings Limited
Via GlobeNewswire
News headline image
Immunocore to present at upcoming investor conferences
From Immunocore Holdings Limited
Via GlobeNewswire
News headline image
Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial
From Immunocore Holdings Limited
Via GlobeNewswire
News headline image
Immunocore announces upcoming presentation and posters at ESMO 2023
From Immunocore Holdings Limited
Via GlobeNewswire
News headline image
Where Immunocore Hldgs Stands With Analysts ↗
 
Via Benzinga
News headline image
Analyst Ratings for Immunocore Hldgs ↗
 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Cancer Focused Immunocore Leads The Way In TCR Therapeutics, Positioned For Success: Analyst Says ↗
Needham has initiated coverage on Immunocore Holdings Plc (NASDAQ: IMCR) with a Buy rating and  
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2023 ↗
 
Via Benzinga
News headline image
Immunocore to present at upcoming investor conferences
From Immunocore Holdings Limited
Via GlobeNewswire
News headline image
Institutions are Buying These 3 Stocks and Analysts Agree
Rumble (RUM), Immunocore (IMCR), and STMicroelectronics (STM) are attracting increased institutional interest, presenting potential investment opportunities. 
Via MarketBeat
News headline image
Immunocore to present at upcoming investor conferences
From Immunocore Holdings Limited
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2023 ↗
 
Via Benzinga
News headline image
Immunocore Reports Second Quarter 2023 Financial Results and Provides Business Update
From Immunocore Holdings Limited
Via GlobeNewswire
News headline image
Immunocore to report second quarter 2023 financial results and host call on August 10, 2023
From Immunocore Holdings Limited
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 17, 2023 ↗
 
Via Benzinga
News headline image
Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO
From Immunocore Holdings Limited
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >